HDL Cholesterol:
A risky drug brings hope
NPR
Expert Summary
Hear from experts as they discuss the study findings for HDL cholesterol-boosting drug torcetrapib and why there's still hope amid the failure.
Margarita Tartakovsky
Expert Scorecard
Overall Expert Score
Community Reviews
Overall Community Rating:
(0 reviews)
Add your rating:
click to select